SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: smh who wrote (5413)1/12/2002 6:38:47 PM
From: Miljenko Zuanic  Respond to of 52153
 
<<Are you suggesting the the recent failure rate should be expected to continue?>>

Not at this rate, but we will have bad news here and there. We will also have good news, success.

Cancer field is still *land of opportunity. Unfortunately, short-cuts and lousy targets and candidates (which are characteristics for this field, many candidates continue with PIII phase only because pts are desperate for new therapy) will bring bad image for while.

Miljenko